859 related articles for article (PubMed ID: 17602984)
1. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
[TBL] [Abstract][Full Text] [Related]
2. Delayed enhancement in hypertrophic cardiomyopathy: comparison with myocardial tagging MRI.
Kim YJ; Choi BW; Hur J; Lee HJ; Seo JS; Kim TH; Choe KO; Ha JW
J Magn Reson Imaging; 2008 May; 27(5):1054-60. PubMed ID: 18425835
[TBL] [Abstract][Full Text] [Related]
3. Delayed enhancement on cardiac magnetic resonance and clinical, morphological, and electrocardiographical features in hypertrophic cardiomyopathy.
Satoh H; Matoh F; Shiraki K; Saitoh T; Odagiri K; Saotome M; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
J Card Fail; 2009 Jun; 15(5):419-27. PubMed ID: 19477402
[TBL] [Abstract][Full Text] [Related]
4. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.
Esposito A; De Cobelli F; Perseghin G; Pieroni M; Belloni E; Mellone R; Canu T; Gentinetta F; Scifo P; Chimenti C; Frustaci A; Luzi L; Maseri A; Maschio AD
Heart; 2009 Mar; 95(3):228-33. PubMed ID: 18708417
[TBL] [Abstract][Full Text] [Related]
5. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.
Maron MS; Appelbaum E; Harrigan CJ; Buros J; Gibson CM; Hanna C; Lesser JR; Udelson JE; Manning WJ; Maron BJ
Circ Heart Fail; 2008 Sep; 1(3):184-91. PubMed ID: 19808288
[TBL] [Abstract][Full Text] [Related]
6. [Left ventricular diastolic properties in dilated cardiomyopathy, transmural myocardial infarction, and hypertrophic cardiomyopathy].
Imai S; Hosoi T; Kawai Y; Kanesawa N; Kanda H; Suzuki T; Murata K
J Cardiogr; 1985 Mar; 15(1):147-53. PubMed ID: 4067340
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular diastolic function assessed with cardiovascular magnetic resonance imaging and exercise capacity in patients with non-obstructive hypertrophic cardiomyopathy.
Małek LA; Chojnowska L; Kłopotowski M; Misko J; Dabrowski M; Kuśmierczyk-Droszcz B; Maczyńska R; Piotrowicz E; Ruzyłło W
Kardiol Pol; 2009 Jan; 67(1):1-6; discussion 7-8. PubMed ID: 19253184
[TBL] [Abstract][Full Text] [Related]
8. Quantification of enhancement of left ventricular myocardium in patients with dilated cardiomyopathy using delayed enhanced MR imaging.
Sueyoshi E; Sakamoto I; Hayashida T; Uetani M
Comput Med Imaging Graph; 2009 Oct; 33(7):547-52. PubMed ID: 19545975
[TBL] [Abstract][Full Text] [Related]
9. Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome.
Machii M; Satoh H; Shiraki K; Saotome M; Urushida T; Katoh H; Takehara Y; Sakahara H; Ohtani H; Wakabayashi Y; Ukigai H; Tawarahara K; Hayashi H
Magn Reson Imaging; 2014 Feb; 32(2):118-24. PubMed ID: 24315973
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of left and right ventricular ejection and filling parameters of the heart using cine-MRI with breath holding technique. Clinical study of 42 patients with cardiomyopathy and coronary heart disease].
Rominger MB; Bachmann GF; Geuer M; Puzik M; Ricken WW; Rau WS
Rofo; 1999 Jun; 170(6):534-41. PubMed ID: 10420902
[TBL] [Abstract][Full Text] [Related]
11. Myocardial enhancement on magnetic resonance imaging with gadolinium-diethylenetriamine pentaacetic acid and improvement of left ventricular function in patients with dilated cardiomyopathy.
Akisawa M; Matsumura Y; Kitaoka H; Yamasaki N; Takata J; Doi Y
J Cardiol; 2002 Oct; 40(4):145-52. PubMed ID: 12420668
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
[TBL] [Abstract][Full Text] [Related]
13. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
[TBL] [Abstract][Full Text] [Related]
14. Functional description of the left ventricle in patients with volume overload, pressure overload, and myocardial disease using cine magnetic resonance imaging.
Wagner S; Auffermann W; Buser P; Semelka RC; Higgins CB
Am J Card Imaging; 1991 Jun; 5(2):87-97. PubMed ID: 10147590
[TBL] [Abstract][Full Text] [Related]
15. [Right ventricular function in cardiovascular disease evaluated by magnetic resonance imaging].
Imai H; Kobayashi S; Sakakibara M; Watanabe S; Masuda Y; Inagaki Y
J Cardiol; 1988 Sep; 18(3):683-93. PubMed ID: 3249284
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced cardiovascular magnetic resonance in primary and ischemic dilated cardiomyopathy.
Calore C; Cacciavillani L; Boffa GM; Silva C; Tiso E; Marra MP; Bacchiega E; Corbetti F; Iliceto S
J Cardiovasc Med (Hagerstown); 2007 Oct; 8(10):821-9. PubMed ID: 17885521
[TBL] [Abstract][Full Text] [Related]
17. [Left ventricular diastolic reserve during acute pressure loading in hypertrophic cardiomyopathy and dilated cardiomyopathy].
Yokote Y; Okamoto M; Sakura E; Shimamoto H; Amioka H; Yamagata T; Hashimoto M; Tsuchioka Y; Matsuura H; Kajiyama G
J Cardiol; 1988 Dec; 18(4):1051-60. PubMed ID: 3267714
[TBL] [Abstract][Full Text] [Related]
18. [Patterns of delayed-enhancement in MRI of ischemic and non-ischemic cardiomyopathies].
Stork A; Müllerleile K; Bansmann PM; Koops A; Meinertz T; Adam G; Lund GK
Rofo; 2007 Jan; 179(1):21-30. PubMed ID: 17203440
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance.
McCrohon JA; Moon JC; Prasad SK; McKenna WJ; Lorenz CH; Coats AJ; Pennell DJ
Circulation; 2003 Jul; 108(1):54-9. PubMed ID: 12821550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
